Literature DB >> 28528853

Sarcomatoid Renal Cell Carcinoma and Collecting Duct Carcinoma: Discrimination From Common Renal Cell Carcinoma Subtypes and Benign RCC Mimics on Multiphasic MDCT.

Jonathan R Young1, Jocelyn A Young2, Daniel J A Margolis2, Steven Sauk2, James Sayre2, Allan J Pantuck3, Steven S Raman2.   

Abstract

RATIONALE AND
OBJECTIVES: To investigate whether imaging features on multiphasic multidetector computed tomography (MDCT) can help discriminate sarcomatoid renal cell carcinoma (RCC) and collecting duct carcinoma (CDC) from other solid renal masses.
MATERIALS AND METHODS: With institutional review board approval for this HIPAA-compliant study, we derived a cohort of 7 sarcomatoid RCCs, 4 CDCs, 165 clear cell RCCs, 56 papillary RCCs, 22 chromophobe RCCs, 49 oncocytomas, and 16 lipid-poor angiomyolipomas with preoperative multiphasic MDCT with up to four phases (unenhanced, corticomedullary, nephrographic, and excretory). Each lesion was reviewed for contour, spread pattern, pattern of enhancement, neovascularity, and calcification.
RESULTS: Sarcomatoid RCCs and CDCs were more likely than other solid renal masses to have an irregular contour (64% vs 2%, P < 0.001) and an infiltrative spread pattern, defined as infiltration into adjacent renal parenchyma, collecting system, or neighboring structures (82% vs 7%, P < 0.001). When used to discriminate sarcomatoid RCC and CDC from other solid renal masses, an infiltrative spread pattern had a specificity of 93% (287/308) and sensitivity of 82% (9/11), and an irregular contour had a specificity of 98% (303/308) and sensitivity of 64% (7/11).
CONCLUSIONS: Solid renal lesions with an irregular contour or an infiltrative spread pattern are suspicious for sarcomatoid RCC or CDC.
Copyright © 2017 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Renal cell carcinoma; collecting duct carcinoma; multidetector computed tomography; sarcomatoid renal cell carcinoma

Mesh:

Year:  2017        PMID: 28528853     DOI: 10.1016/j.acra.2017.03.017

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  5 in total

Review 1.  Epidemiology, biology and treatment of sarcomatoid RCC: current state of the art.

Authors:  Cedric Lebacle; Aydin Pooli; Thomas Bessede; Jacques Irani; Allan J Pantuck; Alexandra Drakaki
Journal:  World J Urol       Date:  2018-06-01       Impact factor: 4.226

2.  Magnetic resonance imaging (MRI) helps differentiate renal cell carcinoma with sarcomatoid differentiation from renal cell carcinoma without sarcomatoid differentiation.

Authors:  Mitsuru Takeuchi; Adam T Froemming; Akira Kawashima; Prabin Thapa; Rickey E Carter; John C Cheville; R Houston Thompson; Naoki Takahashi
Journal:  Abdom Radiol (NY)       Date:  2022-04-05

3.  Partial versus radical nephrectomy for T1b-2N0M0 renal tumors: A propensity score matching study based on the SEER database.

Authors:  Mengping Zhang; Zhijian Zhao; Xiaolu Duan; Tuo Deng; Chao Cai; Wenqi Wu; Guohua Zeng
Journal:  PLoS One       Date:  2018-02-28       Impact factor: 3.240

4.  A CT-Based Radiomics Approach for the Differential Diagnosis of Sarcomatoid and Clear Cell Renal Cell Carcinoma.

Authors:  Xiaoli Meng; Jun Shu; Yuwei Xia; Ruwu Yang
Journal:  Biomed Res Int       Date:  2020-07-24       Impact factor: 3.411

Review 5.  Imaging analysis of 13 rare cases of renal collecting (Bellini) duct carcinoma in northern China: a case series and literature review.

Authors:  Zhehao Lyu; Lili Liu; Huimin Li; Haibo Wang; Qi Liu; Tingting Chen; Meiling Xu; Lin Tian; Peng Fu
Journal:  BMC Med Imaging       Date:  2021-03-06       Impact factor: 1.930

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.